The latest immunotherapy news and developments
Northwestern Medicine (USA) scientists have discovered a new biomarker to identify which patients with glioblastomas…
There are still no established biomarkers to predict the success of immunotherapy in patients with…
Under the right circumstances, the body’s T cells can detect and destroy cancer cells. However,…
Immune checkpoint inhibitors can boost the immune system’s response to tumour cells, but the medications…
Researchers have developed a model that could predict early on in treatment whether cancer patients…
More people with advanced melanoma survive for two years or more when they receive a…
Immunotherapy is the clinical theme of the Clinical Oncology Society of Australia’s 48th Annual Scientific…
Cancer immunotherapy, one of the most important and promising therapies for cancer treatments, is being…
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab plus ipilimumab experienced longer treatment-free survival…
Activating the immune system at the site of a tumour can recruit and stimulate immune…